Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in TaiwanChen‐Hua Liu, Jia‐Horng Kao, Chun‐Jen Liu et al.|Hepatology International|2023Cited by 21